What is the Y-tunnus number of KonePharm Oy?

KonePharm Oy is registered with PRH / YTJ under Y-tunnus 3335044-5.

What is the revenue of KonePharm Oy?

KonePharm Oy reported revenue of 124,4 t. € in 2026.

Who is the CEO of KonePharm Oy?

Jukka Petteri Lehtinen is the CEO of KonePharm Oy.

Who is the chairman of KonePharm Oy?

Päivi Elina Lehtinen chairs the board of KonePharm Oy.

Where is KonePharm Oy headquartered?

KonePharm Oy's registered address is Kaukasuontie 240-A.

Riskpilot← Back to search

Get full access

KonePharm Oy

OYActive

Y-tunnus 3335044-5Kaukasuontie 240A, 46960 MuhniemiConstruction of residential and non-residential buildings· NACE 4100Est. 2023 · 3 years old— employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2026	2025	2024
Revenue	124	152	135
Staff expenses	−86	−99	−93
EBITDA	−4	4	3
Depreciation & amort.	−0	−0	−0
EBIT	−4	4	3
Net financials	−0	−0	0
Profit before tax	−4	4	3
Tax	0	1	1
Net profit	−4	3	3

Balance sheet

EUR thousands

Item	2026	2025	2024
Total assets	9	14	8
Equity	2	6	3
Long-term debt	0	0	0
Short-term debt	7	8	5
Total debt	7	8	5

Financial ratios

5-year trend

EBITDA margin

−3,1 %

This company

15,8 %

Market median

This company

Market median

120% below market

20242026

Equity ratio

19,3 %

This company

38,2 %

Market median

This company

Market median

49% below market

20242026

Return on equity

−224,6 %

This company

18,4 %

Market median

This company

Market median

>999% below market

20242026

Net profit margin

−3,1 %

This company

8,1 %

Market median

This company

Market median

138% below market

20242026

Asset turnover

14,06×

This company

1,12×

Market median

This company

Market median

>999% above market

20242026

Debt / equity

4,18×

This company

0,62×

Market median

This company

Market median

574% above market

20242026

Annual reports & filings

Annual report 2026
Filed via PRH / YTJ · Period 2025-03-01 – 2026-02-28
View PDF
Annual report 2025
Filed via PRH / YTJ · Period 2024-03-01 – 2025-02-28
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-03-01 – 2024-02-28
View PDF

KonePharm Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on KonePharm Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on KonePharm Oy